To: All participants of Tender No. ICB/EPSS6/RDF-R/PH/27/23
Sub: Revised Amendment on the Item Numbers of the Pharmaceuticals
Dear Sirs/Madams,
Thank you for your interest for the participation of the above captioned tender.
Please be informed that an amendment is made to
1. Part 1 section 3, subsection 48.1 Preliminary Qualifications and Capability of the Bidder under I is amended as “Each local agent shall only be authorized by one bidder for the same quoted product in a bid, otherwise the bidders will be rejected. An agent can be authorized by two or more bidders for different quoted products in a bid.”
2. Part 2, Section 6: Statement of requirement under A, technical specification-general requirement of the bidding document, the following items described in the table below are added(included) to this tender hence, the bidders are required to adjust their bid documents accordingly before the submission due date.
The Lists of Items whose quantity are amended
Item No.
Description
Unit
Quantity
9
Bromazepam – 3mg – Tablet
10×10
10,978
11
Carbamazepine – 100mg/5ml – Syrup
100ml
11,897
14
Ciprofloxacin – 2mg/ml in 100ml- Intravenous Infusion (as lactate)
100ml
402,921
15
Clonazepam – 0.5mg – Tablet
10×3
46,950
27
Heparin Sodium – 5000IU/ml in 5ml Ampoule- Injection
Each
473,071
49
Morphine Sulphate – 20mg/5ml – Syrup
125 ml
79,895
57
Risperidone – 2mg – Tablet
10×10
198,658
The Lists of Items which are newly added
Item No.
Description
Unit
Quantity
73
Chlorpromazine HCL – 100mg – Tablet
100×10
11,748
74
Chlorpromazine HCl – 25mg/ml in 2ml – Injection
50
8,368
75
Potassium Chloride – 600mg – Tablet
500
1,983
The closing and opening date and time of the tender are extended to Feb 16, 2024; 2:00 PM and 2:30 PM respectively and the bid price and bid security validity period shall consider the extended closing/opening date accordingly.
All the other terms, conditions, criteria & requirements will be the same.
Finally we apologize for the inconvenience you may face in advance
